Sabra Healthcare REIT (SBRA) has risen sharply, recording gains of 0.83% in the past 4 weeks. However, the stock has corrected -1.34% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 0.44% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
Sabra Health Care REIT, Inc. is up 25.11% in the last 3-month period. Year-to-Date the stock performance stands at 28.33%. The stock has recorded a 20-day Moving Average of 1.4% and the 50-Day Moving Average is 9.68%.
Sabra Healthcare REIT (NASDAQ:SBRA): The stock opened at $24.66 on Friday but the bulls could not build on the opening and the stock topped out at $24.68 for the day. The stock traded down to $24.15 during the day, due to lack of any buying support eventually closed down at $24.37 with a loss of -1.06% for the day. The stock had closed at $24.63 on the previous day. The total traded volume was 290,372 shares.
Also, Equity Analysts at the Citigroup maintains the rating on Sabra Healthcare REIT (NASDAQ:SBRA). The brokerage firm has issued a Neutral rating on the shares. The Analysts at the ratings agency raises the price target from $22 per share to $24 per share. The rating by the firm was issued on August 17, 2016.
Sabra Health Care REIT, Inc. (Sabra) is a self-administered, self-managed real estate investment trust (REIT). Through its subsidiaries, the Company owns and invests in real estate serving the healthcare industry. The Company is primarily engaged in leasing healthcare properties to tenants and operators throughout the United States. It has a diverse portfolio of healthcare investments in the United States that offers a range of services, including skilled nursing/transitional care, assisted and independent living, mental health and acute care. The Companys investment portfolio consists of approximately 160 real estate properties held for investment, including 103 nursing/post-acute facilities, 55 senior housing facilities and two acute care hospitals; over 14 investments in loans receivable, including four mortgage loans, three construction loans, two mezzanine loans and five pre-development loans, and over six preferred equity investments.